Disease/Infection News

RSS

New test could identify resistant tuberculosis faster

Tuberculosis (TB) disease rates in some parts of London are as high as in Sub-Saharan Africa, and drug-resistant strains are becoming increasingly common.

From Oxford Gene Technology 14 May 2015

Immunotherapy for kidney cancer - Phase 3 update from Argos Therapeutics at ASCO

Argos is developing AGS-003, which is a fully personalized immunotherapy designed to induce a durable memory T-cell response specific to each patient’s cancer...

14 May 2015

Men with asthma less likely to develop lethal prostate cancer

Scientists found that men with a history of asthma were 29 percent less likely to have been diagnosed with prostate cancer that spread or to have died of their prostate cancer...

14 May 2015

Researchers receive NSF RAPID response grants to develop computer model for Ebola spread

Identifying and tracking individuals affected by the Ebola virus in densely populated areas presents a unique and urgent set of challenges in public health surveillance.

14 May 2015

MD Anderson researchers find significant clinical variations among liver cancer patients

Significant clinical variations exist among patients with the most common type of liver cancer called hepatocellular carcinoma (HCC), depending on the viral cause of the disease -hepatitis B virus (HBV) or hepatitis C virus (HCV). These differences suggest that hepatitis status should be considered when developing treatment plans for newly diagnosed patients, according to researchers at The University of Texas MD Anderson Cancer Center.

14 May 2015

ART eligibility shorter for male HIV patients in rural South Africa

Male HIV patients in rural South Africa reach the low immunity levels required to become eligible for antiretroviral treatment in less than half the time it takes for immunity levels to drop to similar levels in women, according to new research from the University of Southampton.

14 May 2015

New Johns Hopkins Lyme Disease Clinical Research Center launched

Fundamental research into the causes and cures of post-treatment Lyme disease syndrome now has its first home base at a major U.S. medical research center with the launch of the Johns Hopkins Lyme Disease Clinical Research Center. Inaugurated on May 12, 2015, with a major gift from the Lyme Disease Research Foundation, the center plans an ambitious research program targeting this increasingly common disease, which costs the U.S. economy up to $1.3 billion per year in treatment costs alone.

14 May 2015

TSRI researchers find interferon beta protein as prime suspect in persistent viral infections

Interferon proteins are normally considered virus-fighters, but scientists at The Scripps Research Institute have found evidence that one of them, interferon beta (IFNβ), has an immune-suppressing effect that can help some viruses establish persistent infections.

14 May 2015

IQWiG examines the added benefit of aclidinium bromide/formoterol drug combination in COPD patients

The fixed-dose combination aclidinium bromide/formoterol has been approved since November 2014 for long-term treatment of adults with chronic obstructive pulmonary disease (COPD).

14 May 2015

TB Alliance announces start of clinical trial to treat XDR-TB

TB Alliance and its partners announced the start of a clinical trial of a new regimen to treat extensively drug-resistant tuberculosis (XDR-TB). It is the first study to test an all-oral drug regimen, comprised of drugs with minimal pre-existing resistance, that has the potential to shorten, simplify, and improve treatment for XDR-TB.

14 May 2015

Bronchitis can cause pneumonia, says Loyola physician

When a cold has lasted too long or a cough is especially bothersome, it's important to see a medical professional.

14 May 2015

UCL-led team develops new technique to find resistant TB faster

The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.

From Oxford Gene Technology 13 May 2015

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

A simple blood test can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy, according to a report in the May issue of Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association.

13 May 2015

FDA licenses Protein Sciences' Pearl River, NY facility to manufacture Flublok influenza vaccine

Protein Sciences Corporation announced that on May 12, 2015 the U.S. Food and Drug Administration licensed its Pearl River, NY manufacturing facility for the commercial manufacturing of Flublok influenza vaccine. Flublok is the world's first licensed influenza vaccine made using modern recombinant technology.

13 May 2015

Emergency preparedness pays off as Kathmandu hospitals respond to earthquakes

As of today, more than 8200 people are reported to have been killed in the earthquakes and over 19,000 injured...

13 May 2015

Unique rheumatoid arthritis diagnostics tool to launch at Hospitalar 2015

An exclusive solution to improve the diagnosis speed of rheumatoid arthritis - one of the world's five most financially burdensome illnesses for the health insurance systems – will be launched by BGE Systems Ltd at Hospitalar 2015...

13 May 2015

New approach to vaccine development is 97 per cent efficacious and could eliminate shingles

A new vaccine has proven almost completely effective in preventing shingles (disease medical name: herpes zoster), an extremely painful nerve infection which affects a third of Australians; most over the age of 50...

13 May 2015

Researchers present new model for evaluating malaria treatment programs across multiple countries

In a study published this month in Malaria Journal, researchers from Uppsala University and other institutions present a new model for systematically evaluating new malaria treatment programs in routine conditions across multiple countries.

13 May 2015

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

The European Investment Bank (EIB), the world’s largest multilateral bank, today reaffirmed its firm commitment to respond to the Ebola pandemic. The Bank has provided a EUR 50 million loan to Bavarian Nordic, an international biopharmaceutical company, for accelerated development of an Ebola vaccine with long-term efficacy. The financing is also backing research into vaccines for treating other infectious diseases and multiple cancer indications.

12 May 2015

Health workers now have rapid test to detect presence of chikungunya virus within an hour

Scientists at a U.S. Army research center have modified an assay that tests whether or not a sample of mosquitoes harbors the virus responsible for the disease known as chikungunya (CHIKV), long a problem in the Old World tropics but recently established in the Americas.

12 May 2015

Disease/Infection News

New test could identify resistant tuberculosis faster

Immunotherapy for kidney cancer - Phase 3 update from Argos Therapeutics at ASCO

Men with asthma less likely to develop lethal prostate cancer

Researchers receive NSF RAPID response grants to develop computer model for Ebola spread

MD Anderson researchers find significant clinical variations among liver cancer patients

ART eligibility shorter for male HIV patients in rural South Africa

New Johns Hopkins Lyme Disease Clinical Research Center launched

TSRI researchers find interferon beta protein as prime suspect in persistent viral infections

IQWiG examines the added benefit of aclidinium bromide/formoterol drug combination in COPD patients

TB Alliance announces start of clinical trial to treat XDR-TB

Bronchitis can cause pneumonia, says Loyola physician

UCL-led team develops new technique to find resistant TB faster

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

FDA licenses Protein Sciences' Pearl River, NY facility to manufacture Flublok influenza vaccine

Emergency preparedness pays off as Kathmandu hospitals respond to earthquakes

Unique rheumatoid arthritis diagnostics tool to launch at Hospitalar 2015

New approach to vaccine development is 97 per cent efficacious and could eliminate shingles

Researchers present new model for evaluating malaria treatment programs across multiple countries

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

Health workers now have rapid test to detect presence of chikungunya virus within an hour

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News